Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2
Anticancer Research · 2025-05 · 45 (5) · 2137-2146
DOI: 10.21873/anticanres.17588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 28.04.2025. Verfasst von Nina Boe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany nina.boe@gmx.net. Hauptthemen laut MEDLINE: Neurofibromatosis 2, Neuroma, Acoustic, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND/AIM: NF2-related schwannomatosis, formerly known as Neurofibromatosis type 2 (NF2) is characterized by bilateral vestibular schwannomas (VS). Managing NF2 requires balancing watchful waiting with surgical intervention, each carrying inherent risks. While these risks are acknowledged, they have not yet been subjected to systematic investigation. Accurate prognosis of tumor growth is crucial for clinical decision-making. This study investigated radiomics features from longitudinal magnetic resonance imaging (MRI) data to predict VS growth. PATIENTS AND METHODS: Radiomics features were extracted from cranial MRIs of 32 NF2 patients, each with at least two or more imaging time points. The association between these features and tumor growth was analyzed through correlation, visual inspection, and the Boruta algorithm. RESULTS: Correlations between growth rates and radiomics features were weak (ρ≤0.23, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany nina.boe@gmx.net.
- Department of Neurology, University Hospital Hamburg Eppendorf, Hamburg, Germany.
- Department of Oral and Maxillofacial Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany.
- Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany.
- Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany koeppen@ieee.org.
Zitieren
APA
Boe, N., Mautner, V. F., Friedrich, R. E., Farschtschi, S. C., Dührsen, L., Meyer, H. S., & Koeppen, J. A. (2025). Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2. Anticancer Research, 45(5), 2137-2146. https://doi.org/10.21873/anticanres.17588
Vancouver
Boe N, Mautner VF, Friedrich RE, Farschtschi SC, Dührsen L, Meyer HS, et al. Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2. Anticancer Research. 2025;45(5):2137-2146. doi:10.21873/anticanres.17588
BibTeX
@article{Boe2025,
author = {Boe, Nina and Mautner, Victor F and Friedrich, Reinhard E and Farschtschi, Said C and Dührsen, Lasse and Meyer, Hanno S and Koeppen, Johannes A},
title = {Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2},
journal = {Anticancer Research},
year = {2025},
volume = {45},
number = {5},
pages = {2137--2146},
doi = {10.21873/anticanres.17588}
}
EUVIMED